Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Impedimed Ltd Ord (IPDQF)

Impedimed Ltd Ord (IPDQF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.96
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0140 unch
on 02/10/26
0.0260 -46.15%
on 01/13/26
-0.0120 (-46.15%)
since 01/05/26
3-Month
0.0140 unch
on 02/10/26
0.0260 -46.15%
on 01/13/26
+0.0022 (+18.64%)
since 10/16/25
52-Week
0.0099 +41.41%
on 07/03/25
0.0514 -72.76%
on 07/21/25
-0.0260 (-65.00%)
since 02/06/25

Most Recent Stories

More News
ImpediMed Limited Announces Details for Upcoming Online AGM

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Impedimed...

IPDQF : 0.0140 (-17.65%)
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Impedimed Limited (OtherIPDQF) and Humana (HUM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apellis Pharmaceuticals (APLS – Research Report), Impedimed Limited (IPDQF – Research Report) and Humana (HUM – Research...

HUM : 185.25 (-2.78%)
APLS : 20.37 (-2.81%)
IPDQF : 0.0140 (-17.65%)
Impedimed Limited Announces Cessation of Securities

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

IPDQF : 0.0140 (-17.65%)
Impedimed Limited Issues 17.25 Million Unquoted Equity Securities

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

IPDQF : 0.0140 (-17.65%)
Canaccord Genuity Reaffirms Their Buy Rating on Impedimed Limited (IPDQF)

In a report released on October 3, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Impedimed Limited, with a price target of A$0.07. The company’s shares closed last Friday at $0.03.Elevate...

IPDQF : 0.0140 (-17.65%)
ImpediMed Gains Major US Insurance Coverage for Lymphedema Assessment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

IPDQF : 0.0140 (-17.65%)

Business Summary

Impedimed Ltd was founded in Brisbane, Australia in October 1999, and was listed on the ASX on 24 October 2007. The Company is engaged in the development, manufacture and sale of bioimpedance instruments and consumables and the sale of electronic test and measurement devices. It operates in the following...

See More

Key Turning Points

3rd Resistance Point 0.0140
2nd Resistance Point 0.0140
1st Resistance Point 0.0140
Last Price 0.0140
1st Support Level 0.0140
2nd Support Level 0.0140
3rd Support Level 0.0140

See More

52-Week High 0.0514
Fibonacci 61.8% 0.0355
Fibonacci 50% 0.0306
Fibonacci 38.2% 0.0258
Last Price 0.0140
52-Week Low 0.0099

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar